Atlas Venture Fund Xii, , a Delaware limited partnership (“AVA XI

Atlas Venture Fund Xii, , a Delaware limited partnership (“AVA XI LP”) and Atlas … Atlas Venture announces the successful closing of its $450 million Fund XIV, aimed at driving biotech innovation and developing groundbreaking medicines for patients. (NasdaqGS:VIGL) from Atlas Venture Fund XII, L. The general partner of Atlas Venture Fund XI is Atlas Venture Associates XI, L. -- (BUSINESS WIRE)-- Atlas Venture, a leading early stage venture capital firm investing in groundbreaking … Atlas Venture Opportunity Fund III equips Atlas to continue providing longitudinal capital to its portfolio companies as they raise … An easy way to get Atlas Venture Fund XII, L. Atlas Venture Fund XI L. Atlas is headquartered in Cambridge Atlas Venture Fund XII, L. With the close of the fund, Atlas Venture said it will continue to advance … Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, announced the closing of its twelfth fund, raising $400 million in a highly … ATLAS VENTURE FUND XII, L. Transaction History Direct Ownership Indirect Ownership Date Transaction Value Shares Traded Form Jan 112022 BUY Conversion of derivative security - … Atlas Venture Fund X LP published this content on December 17, 2025, and is solely responsible for the information contained herein. - Most recent fund raising on December 18, 2014 raised $0 in Other Atlas Venture Fund X, L. 1 Signature of Reporting Persons: This statement on Form 4 is filed by Atlas Venture Associates VI, L. Atlas Venture is headquartered in 300 Technology Square 8th Floor. (12/1/21). The fund was oversubscribed and closed … Discover Company Info on ATLAS VENTURE FUND XII, L. Schedule 13D/A Filing Concerning VIGL on 2025-08-05 Boston, June 8, 2020 - Proskauer, a leading international law firm, announced that it advised Atlas Venture on the formation of Atlas Venture Fund XII. Table_II - SEC. Historical performance, showing investment return and comparing it to SP 500. , a Delaware limited partnership (“AVA XII LP”) and … PRESS RELEASE CAMBRIDGE, Mass. ATLAS AROUND THE ECOSYSTEM Jason Rhodes speaks at the 2017 Capital W Boston Women’s Venture Summit Peter Barrett becomes chair of Harvard Business School’s … Insider trades for Atlas Venture Fund X, L. Atlas works … Sanofi entered into a definitive merger agreement to acquire Vigil Neuroscience, Inc. In January 2019 Atlas Venture raised $250 million for its Opportunity Fund I, a complementary strategy focusing investment in growth financings of companies in Atlas' main fund portfolios. Form 144 Disc Medicine, Inc. , a Delaware limited partnership (“Atlas X”), Atlas Venture Associates X, L. p. Sep 15, 2023 04:57PM … Cambridge, Mass. SEC Filings include 13F quarterly reports, 13D/G events and more. Direct links to the EDGAR source material. View the latest funds and 13F holdings. , Atlas Venture Fund VI GmbH & Co. , a Delaware limited partnership (“AVA X LP”) and Atlas … "Press Release: GRO Biosciences Closes $60M Series B Financing Co-Led by Atlas Venture and Access Biotechnology". Atlas Venture Fund X has made numerous investments in companies like Spero Therapeutics, Secret Escapes, and Currencycloud within the Biotechnology, Restaurants, … Track the AUM, funds, and holdings for Atlas Venture Fund VII L P over time. , a Delaware limited partnership (“AVA XII LP”) and … Track Atlas Venture Fund IX L. S. The fund is located in Cambridge, Massachusetts and invests in the United States. Distributed via Edgar on December 18, 2025 … Atlas Venture Fund XII L. Atlas Venture Associates X, … Kyle Justin Loudermilk Сделки инсайдера Atlas Venture Fund XII, L. Overall, Atlas Venture portfolio has seen 5 unicorns, 33 IPOs and 156 acquisitions including key companies like DraftKings, VMware and Patreon. The fund is located in Cambridge,Massachusetts. Long and Short Trading … Atlas Venture Fund XII, 有限合夥人 投資組合持倉基本數據 内幕人士資料 Atlas Venture Fund XII, L. KG ( Atlas VI GmbH ), Atlas Venture Associates VI, L. … Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a highly … Atlas Venture Fund XII L. , a Delaware limited partnership (“AVA XII LP”) and … Atlas Venture Associates XII, LLC ("AVA XII LLC") is the general partner of AVA XII LP. , a Delaware limited partnership (“AVA XII LP”) and … * Atlas Venture Fund IX, L. Boston, June 8, 2020 - Proskauer, a leading international law firm, announced that it advised Atlas Venture on the formation of Atlas Venture Fund XII. , Atlas Venture Associates XII, LLC, … Aerovate Therapeutics / Atlas Venture Fund XII ownership change, SC 13D/A SEC filing by Atlas Venture Fund XII on 5 May 22, 4:04pm Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a highly … Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a highly … Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a highly … SEC FORM 4SEC Form 4 Atlas Venture Fund Xii (ZAFEZX) stock price, charts, trades & the US's most popular discussion forums. Prominent biotech VC firm Atlas Venture has another $400 million to invest in drug companies. , a Delaware limited partnership (“Atlas X”) beneficially own 2,664,036 shares of the Issuer’s Common Stock that are directly held by … Detailed Profile of ATLAS VENTURE FUND VIII, L. is the 10% Owner of Vigil Neuroscience Inc and owns … "Press Release: Rectify Pharmaceuticals Launches with $100 Million Series A Financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund". 2023 was Atlas Venture Fund X, L. Home Earnings IPOs Transcripts Investor Holdings Filings Holdings Transcripts ETFs Insider Institutional Shorts Profile … The Reporting Person is a member of AVA XII LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund XII, except to the extent of his pecuniary interest therein, … As described in Item 5 below, Atlas Venture Fund X, L. Form 4 for Atlas Venture Fund XI LP filed 12/14/2022 CAMBRIDGE, Mass. These … Atlas Venture, one of the leading venture capital firms in the biotech industry, has raised $450 million for a new fund, the firm’s leaders … Track the AUM, funds, and holdings for Atlas Venture Fund XII, L. View Atlas Venture Fund XII, L. portfolio of holdings. 1 - Amendment … ATLAS VENTURE FUND XII, L. Filed by: Atlas Venture Fund X, L. The Reporting Person is a member of AVA XII LLC and disclaims beneficial ownership of such … Atlas Venture announces the closing of Atlas Venture Fund XIII, a $450M fund to invest in breakthrough biotech company creation. Atlas Venture announces the closing of Fund XIV, a $450M fund to invest in breakthrough biotech company creation. cashed out on 7,976,754 shares for a total of $0. Ryan is Shareholder, Director, Vice President and has served as Shareholder, Director, Vice President … Atlas Venture announces the closing of Fund XIV, a $450M fund to invest in breakthrough biotech company creation. Portföljvärde $ 378 348 Aktuella positioner 2 Aktivistpositioner 2 Latest SEC filings for Atlas Venture Fund XII. (3/3/22). View live ZAFEZX stock fund chart, financials, and market news. F 4. Schedule 13D and 13G filing information for institutional investment manager or hedge fund ATLAS VENTURE FUND XII, L. . and … Atlas Venture is a leading biotech venture capital firm. Taking a global view of scientific … Disc Medicine / Atlas Venture Fund X ownership change, SC 13D/A SEC filing by Disc Medicine on 14 Feb 23, 12:00am Engage in discussions with fellow traders via ZAFEZX Minds. , Atlas Venture Opportunity Fund I managed by Atlas … Atlas Venture collaborates with experienced venture partners and entrepreneurs-in-residence to found, seed, incubate, and invest in new biotech startups. Atlas Venture Fund Xii, L. Portfolio HoldingsZákladní statistiky Zasvěcený profil Atlas Venture Fund XII, L. Public filings of Atlas Venture Fund VIII LP raised by Atlas Venture Advisors Inc. STAA Top NewsMost ReadSpecial Reports December 16, … Atlas Venture Fund Xii is based out of Cambridge. , a Delaware limited partnership (“Atlas XII”), Atlas Venture Associates XII, L. Sales Commissions & Finder's Fees Expenses … Track the AUM, funds, and holdings for Atlas Venture Fund VI LP over time. is > 10% Shareholder of Aerovate Therapeutics, Inc. SPY 2. … As described in Item 5 below, Atlas Venture Fund XII, L. sec form 13D/13G filings, stock buying and selling. Red rows indicate closed positions. , a Delaware limited partnership (“Atlas X”) beneficially owns 166,501 shares of the Issuer’s Common Stock that are directly held by … News + Filings Transactions Holdings All 13F 13D/G OtherAtlas Venture Fund IX, L. As described in Item 5 below, Atlas Venture Fund XI, L. </p> <p><strong>The GP:</strong></p> <p>Founded in 1984, Atlas is a venture capital firm … Our portfolio companies embody the Atlas culture of collaborative, science-first, patient-centric drug development All Active Exited Seeded Incubated … 12/16/2025 | Press release | Distributed by Public on 12/16/2025 20:43 Statement of Changes in Beneficial Ownership (Form 4) A Kymera Therapeutics director reported multiple common stock sales via Atlas Venture funds on Dec 10–12, 2025, at weighted prices around $88–$93, with millions of shares … Firm Details for ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, Location: Massachusetts, AUM = None, Last Form ADV Filed : 01-April-2025, Officers: Michael, … ATLAS VENTURE FUND X, L. , Atlas Venture Opportunity Fund I managed by Atlas … * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration … As described in Item 5 below, Atlas Venture Fund X, L. Whalewisdom has at least 22 13D filings, 12 13G filings, and 36 Form 4 filings The firm last filed a Form D notice of exempt offering of … As described in Item 5 below, Atlas Venture Fund X, L. html : 20240125 <SEC-HEADER>0001104659-24-006716. Currently has a direct ownership of 2. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) ¨ (b) x 3 SEC … As described in Item 5 below, Atlas Venture Fund XII, L. Atlas Venture announces the closing of Atlas Venture Fund XIII, a $450M fund to invest in breakthrough biotech company creation. 13D/13G Filings for Vigil Neuroscience, Inc. Public filings of Atlas Venture Associates XII LP at Atlas Venture Life Science Advisors LLC located in Cambridge, Ma. Atlas … Atlas Venture Opportunity Fund II is a later-stage venture capital fund managed by Atlas Venture. , Atlas Venture Fund VI, L. , a Delaware limited partnership (“AVA X LP”) and Atlas … Sanofi entered into a definitive merger agreement to acquire Vigil Neuroscience, Inc. This event was filed by … Aerovate insider trading alert for conversion of series a preferred stock by Atlas Venture Fund Xii Lp, the corporate stakeholder, on 6th of July 2021. , Atlas Venture Opportunity Fund I managed by Atlas Venture L. Last Updated January 12, 2022 at 2:11 AM EST Back to Atlas Venture Associates XII, L. "Press Release: Mariana Oncology Raises $75 Million Financing to Further Its Mission of Transforming Cancer Care with Precision … The investing partners in Fund XIV are Kevin Bitterman, Bruce Booth, Michael Gladstone, David Grayzel, and Jason Rhodes. About Atlas Venture Atlas Venture is a leading biotech venture … 11,540,228 19,787,162 10,655,656 5,206,321 707,168 As described in Item 5 below, Atlas Venture Fund X, L. Aerovate Therapeutics / Atlas Venture Fund XII ownership change, SC 13D/A SEC filing by Aerovate Therapeutics on 20 Jul 22, 4:22pm Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a highly … As described in Item 5 below, Atlas Venture Fund X, L. ATLAS VENTURE FUND XI, L. -based Atlas set out in the early spring to raise $350 million for Atlas Venture Fund XII LP, and closed the new early … Atlas Venture Fund XII, L. This page provides a comprehensive analysis of the known insider trading history of Atlas Venture Fund XII, L. As described in Item 5 below, Atlas Venture Fund XII, L. The fund was oversubscribed and closed at its hard cap of $400 million… Nine months after closing a $450 million fundraise, Atlas Venture is back with another biotech financing vehicle, raising $400 … Atlas Venture Fund XII L. CAMBRIDGE, Mass. Green rows indicate new positions. Insiders are officers, directors, or significant investors in a company. </p> <p>Atlas’ investment approach typically involves inception of companies in its in … Public filings of Atlas Venture Fund XII LP raised by Atlas Venture Life Science Advisors LLC. Track positions and transactions. 33 Million shares of AVTE, which is worth approximately $5. After the 12/16/2025 sales, the director reports indirect beneficial ownership of 349,603 Disc Medicine shares through Atlas Venture Opportunity Fund I, 337,698 shares … Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a highly … If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ … Atlas Venture Fund XII, L. With the closing of Fund XIV, … Atlas Venture is a leading biotech venture capital firm. The Reporting Person is a member of AVA XII LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund XII, except to the extent of his pecuniary interest therein, … Cambridge, MA-based investment firm Atlas Venture collected $450M in aggregate capital commitments on the final close of its … The global pandemic accelerated an already fast-moving upward trend of time and money spent on wellness. Transaction History Direct Ownership Indirect Ownership Date Transaction Value Shares Traded Form Jan 112022 BUY Conversion of derivative security - … Atlas Venture, one of the leading venture capital firms in the biotech industry, has raised $450 million for a new fund, the firm’s leaders … Track the AUM, funds, and holdings for Atlas Venture Fund XII, L. in Wilmington, DE, such as Contacts, Addresses, Reviews, and Registered Agent. Sales Compensation 13. The Insider Trading Activity of Atlas Venture Fund XII, L. Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. P. Schedule 13D/A Filing Concerning SION on 2025-10-16If the filing person has previously filed a statement on Schedule 13G to report the … Its representatives didn’t immediately respond to AnalyzeMarkets’ request for comment. Form 4 Insider Filing Concerning VIGL on 2025-08-05 Vigil Neuroscience / Atlas Venture Fund XII ownership change, SC 13D SEC filing by Atlas Venture Fund XII on 21 Jan 22, 4:39pm Cambridge, MA Investment Fund Type Venture Capital Fund Industry Group Pooled Investment Fund Related People Atlas Venture Associates XII, L. --(BUSINESS WIRE)--Atlas Venture, a leading early stage … Each of Atlas I LP and AVAO LLC disclaim Section 16 beneficial ownership of the securities owned by Atlas Fund I. , a Delaware limited partnership (“AVA XII LP”) and … Atlas Venture Fund VI, L. reports a 12. , a Delaware limited partnership (“Atlas XI”), Atlas Venture Associates XI, L. ( 2 ) Represents 510,000 shares issued in the private placement of … All Categories Atlas Venture News From the Trenches LifeSciVC Portfolio Company News December 12, 2025 Atlas Venture Fund XIV is a 2025 vintage early-stage venture capital fund managed by Atlas Venture. Bruce is Shareholder, Director, Vice President and has served as Shareholder, Director, Vice President … Atlas Venture Fund XI is a 2017 vintage venture capital fund managed by Atlas Venture. , a Delaware limited partnership (“AVA XI LP”) and Atlas … Atlas Venture Fund Xiii (ZAFFCX) stock price, charts, trades & the US's most popular discussion forums. Atlas Venture Fund X is based out of Cambridge. discloses stake in AVTE / Aerovate Therapeutics, Inc. hdr. Atlas … Track the AUM, funds, and holdings for Atlas Venture Associates XII, L. Atlas Venture Fund XIV, L. over time. : | Fiscal Year End: Type: Mailing Address 400 TECHNOLOGY SQUARE10TH FLOOR CAMBRIDGE MA 02139 Business … (CF Office: 03 Life Sciences) Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 Business Address 400 TECHNOLOGY SQUARE 10TH … <SEC-DOCUMENT>0001104659-24-006716-index. and … Stock screener for investors and traders, financial visualizations. Sep 15, 2023 06:44PM Form SC 13D/A Dianthus Therapeutics, Filed by: Atlas Venture Fund X, L. 12. Taking a global view of scientific … APC Opportunity Fund XII is a venture capital fund managed by Atlas Peak Capital. Atlas Venture is a biotechnology venture capital firm that focuses on partnering with life science entrepreneurs to develop scientific advancements into medicines, … Exhibit 99. Taking a global view of scientific … Atlas’ Opportunity Fund II arm, a $300 million investment repository created last year, is also on hand to back companies that are honing advanced therapeutics programs. is at least $14 Million dollars as of 2024-12-03. See current ownership, buyers and sellers. Includes transcripts, social sentiment, and more. Taking a global view of scientific … Trading history and investment stats from Atlas Venture Fund Xii, L. insider trading, stock ownership, and SEC Form 4 filings. gov Table_II Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a highly … Atlas Venture, a Cambridge, Massachusetts-based early-stage venture capital firm that creates and invests in biotech startup companies, today announced it has closed $400 … Atlas Venture, a Cambridge, Massachusetts-based early-stage venture capital firm that creates and invests in biotech startup companies, … Atlas Venture Fund XII L. Whalewisdom has at least 6 13D filings, and 4 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2020-06-04. Advisors Lp with 1,831,789 shares representing 7. In 2021 Atlas Venture Fund XII, L. Offering and Sales Amounts Clarification of Response (if Necessary): 14. Atlas Venture closes on $450m for oversubscribed 14th fund "It’s fair to say this fundraising was the smoothest, most efficient, and most oversubscribed fundraise we’ve had in … Atlas Beyond Ventures is a global venture capital arm dedicated to empowering fintech and technology innovators redefining financial systems to better serve people and … 1 NAMES OF REPORTING PERSONS: ATLAS VENTURE FUND X, L. Atlas Venture - We build breakthrough biotechnology companies. , December 05, 2024--Atlas Venture announces the closing of Fund XIV, a $450M fund to invest in breakthrough biotech … Atlas Venture is a biotech investment firm that creates and builds breakthrough biotechnology companies, partnering with the world's best life science entrepreneurs to translate … Atlas Venture successfully raised $450 million at the close of its thirteenth fundraising activity to support efforts to create and invest in new biotech firms that address … Stock screener for investors and traders, financial visualizations. Track the AUM, funds, and holdings for Atlas Venture Fund XII, L. KG, Atlas … Atlas Venture collaborates with experienced venture partners and entrepreneurs-in-residence to found, seed, incubate, and invest in new biotech startups. : | State of Incorp. Cambridge-based, venture capital firm Atlas Ventures has raised $400 million to build breakthrough biotech startups in a highly … Atlas Venture Associates XII L. Ten Percent Owner at Aerovate Therapeutics, is currently unranked, see this insider's latest transactions. - Statement of Acquisition of Beneficial Ownership by an "Active" Investor - Seq. General Information Description Atlas Venture Fund XIII is a venture capital fund managed by Atlas Venture. This event was filed by … Proskauer Rose advised Atlas Venture on the formation of Atlas Venture Fund XII. The fund will focus on making seed investments … As described in Item 5 below, Atlas Venture Fund XII, L. Atlas Venture Fund XII insider trading activity. - ‘SC 13D/A’ on 7/20/22 re: Aerovate Therapeutics, Inc. Usearch … Atlas Venture Fund X L. Thirty years at the leading-edge of medical innovation and we’re just getting … Massachusetts-based VC shop Atlas Ventures has drawn together another $450 million fund to be channeled toward innovative … Leading early-stage venture capital firm Atlas Venture announced that it closed its twelfth fund at $400 million as part of a highly oversubscribed … Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a highly … With the closing of Fund XII, Michael Gladstone was promoted to partner. "Press Release: Atlas … Get the latest news, data and filings for Atlas Venture Fund XII, with free alerts. по дате Воспользуйтесь дополнительными инструментами BestStocks Прогнозы аналитиков Получайте самые … Atlas Venture, a Cambridge, MA-based venture capital firm investing in biotech, closed its third Opportunity Fund, at $400m. ("AVA XI LP"). , Atlas Venture Opportunity Fund I managed by Atlas … Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its fourteenth fund, raising $450 million in … New fund will invest growth capital in Atlas-backed biotech companiesCAMBRIDGE, Mass. NAVN 5. Document Format Files Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 Business Address 400 TECHNOLOGY SQUARE 10TH … Atlas Venture Closes Fund XII at $400 Million, Promotes Gladstone to Partner Track the AUM, funds, and holdings for Atlas Venture Associates XII, LLC over time. Atlas Venture Fund XII, L. Stock screener for investors and traders, financial visualizations. Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a … In January 2019 Atlas Venture raised $250 million for its Opportunity Fund I, a complementary strategy focusing investment in growth financings of companies in Atlas' main fund portfolios. Schedule 13D/A Filing Concerning JBIO on 2025-04-28 Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a highly … "Press Release: Rectify Pharmaceuticals Launches with $100 Million Series A Financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund". Click the link icon to see the full transaction history. Tracking the trades of over 10,800 corporate insiders and strives to provide accurate and reliable information on their … Atlas Venture collaborates with experienced venture partners and entrepreneurs-in-residence to found, seed, incubate, and invest in new biotech startups. from Atlas Venture Fund XII, L. Beneficial ownership report (amended), SCHEDULE 13D/A SEC filing by Atlas Venture Fund XII on 7 Aug 25, 5:11pm Thirty years at the leading-edge of medical innovation and we’re just getting started. Atlas Venture Associates XI, L. CENTRAL INDEX KEY: 0001812049 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE … In December 2024, Atlas Venture announced the closing of its fourteenth fund, raising $450 million to invest in early-stage biotech startups. ACN 7. The fund was oversubscribed and closed … Schedule 13D and 13G filing information for institutional investment manager or hedge fund ATLAS VENTURE FUND XII, L. … Atlas Venture Announces $450 Million Fund XIVAtlas Venture News December 9, 2025 Stock screener for investors and traders, financial visualizations. The Atlas Wellness Portfolio invests in physical, nutritional, and mental wellness … Track the AUM, funds, and holdings for Atlas Venture Associates X, LLC over time. TSLA 3. Taking a global view of scientific … Atlas Venture has made numerous investments in companies like Lifordi Immunotherapeutics, Aavantgarde, and Kailera Therapeutics within the … Atlas Venture, a Cambridge, Massachusetts-based early-stage venture capital firm that creates and invests in biotech startup companies, today announced it has closed $400 … Atlas Venture collaborates with experienced venture partners and entrepreneurs-in-residence to found, seed, incubate, and invest in new biotech startups. Including company executives, business partners, clauses and more. – (BUSINESS WIRE)– Atlas Venture, a leading early stage venture capital firm investing in groundbreaking … 12. 0bn across three funds since 2017. Sales Commissions & Finder's Fees Expenses Provide … Atlas Venture Fund XII, L. Investors 15. (VIGL) Atlas Venture Fund XII, L. … Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments. Sanofi entered into a definitive merger agreement to acquire Vigil Neuroscience, Inc. Atlas Venture Associates XII LLC sec form 4 filings insider trading, insiders stock buying and selling. … Schedule 13D and 13G filing information for institutional investment manager or hedge fund ATLAS VENTURE FUND XII, L. Taking a global view of scientific … Sanofi entered into a definitive merger agreement to acquire Vigil Neuroscience, Inc. Atlas … Sanofi (ENXTPA:SAN) entered into a definitive merger agreement to acquire Vigil Neuroscience, Inc. 's insider trading history, current holdings, and transaction details. , a Delaware limited partnership (“AVA XII LP”) and … Atlas Venture collaborates with experienced venture partners and entrepreneurs-in-residence to found, seed, incubate, and invest in new biotech startups. Explore the NASDAQ:ZAFEZX forum and gain insights from millions of investors. Atlas Venture has also managed funds with unknown amounts, such as Atlas Venture Fund XII and Pride Fund, both of which closed in 2020. Free forex prices, toplists, indices and lots more. sgml : 20240125 <ACCEPTANCE … As described in Item 5 below, Atlas Venture Fund XI, L. SEC Form 3 Filed January 6, 2022: Initial statement of beneficial owner Atlas Venture closed Fund XII with more than $400 million. New fund will invest growth capital in Atlas-backed biotech companies Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech … Track the AUM, funds, and holdings for Atlas Venture Life Science Advisors LLC over time. contracts and agreements from SEC filings. ALC 8. 3 percent passive stake in Intellia Therapeutics Inc as of December 31, 2016 -sec filing Source text: Further company coverage: As described in Item 5 below, Atlas Venture Fund XII, L. – (BUSINESS WIRE)–Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today … Biotech is a team sport All Categories Investment Team Operations Team Venture Partners, Venture Advisors & EIRs Atlas Advisors View Atlas Venture Fund XII, L. gov Table_II Atlas Venture Associates XII, LLC ("AVA XII LLC") is the general partner of AVA XII LP. [2] Atlas Venture. , Atlas Venture Opportunity Fund I … Atlas Venture collaborates with experienced venture partners and entrepreneurs-in-residence to found, seed, incubate, and invest in new biotech startups. SFBS 9. Hodnota portfolia $ 378 348 Aktuální pozice 2 Aktivistické pozice 2 Document Format Files Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 Business Address 400 TECHNOLOGY SQUARE 10TH … Atlas Venture raised $450m for its fourteenth biotech round, while Nuvig, Maze, and Antag also closed financings this week. Compare against similar firms. StreetInsider. Each of AVA XII LP and AVA XII LLC disclaims Section 16 beneficial ownership of the securities held … Atlas Venture Fund XII, L. ( … The shares are held directly by Atlas Venture Fund XI, L. real-time prices. 85 billion for BVP XII, the firm’s twelfth flagship fund, and $780 million for the inaugural BVP … As described in Item 5 below, Atlas Venture Fund XII, L. The estimated net worth of Atlas Venture Fund Xii, L. Aerovate insider trading alert for conversion of series a preferred stock by Atlas Venture Fund Xii Lp, the corporate stakeholder, on 6th of July 2021. , et al. com Top Tickers, 12/16/2025 1. Cambridge, MA. ( AVE VI ), Atlas Venture Fund VI GmbH & Co. Atlas works … Here’s this year’s link: Atlas Venture 2023 Year In Review Special thanks again this year to my Atlas colleagues Aimee Raleigh and Kristen Margeson, who were instrumental … [4] Mariana Oncology Inc. Real-time Insider Trading Stock Screener. Atlas Venture Fund VI has made numerous investments in companies like Azea Networks, Alnylam Pharmaceuticals, and DisplayLink within the Business/Productivity … Atlas Venture is an early-stage venture capital firm that creates and invests in biotechnology startup companies in the U. Usearch discovered 1 location for Atlas Venture including locations in Cambridge · Massachusetts. - SEC Filings - Registrant - CIK 1812049 - 1812049 - View Web - SEC Atlas Venture Fund Xii, L. and … Republished By Plato Atlas Venture, a Cambridge, Massachusetts-based early-stage venture capital firm that creates and invests in biotech startup companies, today … The Insider Trading Activity of Atlas Venture Fund XII, L. Baker Bros. 96 Million. With the goal of doing well by doing good, the company has been building breakthrough biotech startups for over 25 years. sec form 4 filings insider trading, insiders stock buying and selling. This year, we announced the closing of two funds, $3. NOW 10. Pursuant to Rule 13d-1 (k) (1) promulgated pursuant to the Securities Exchange Act of 1934, as amended, the undersigned agree that the attached Schedule 13D is being filed on behalf of … CAMBRIDGE, Mass. - Most recent fund raising on December 5, 2024 raised $450,000,000 in Other We partner with audacious entrepreneurs building enduring businesses. , a Delaware limited partnership (“AVA XI LP”) and Atlas Venture Associates XI, LLC, a Delaware limited liability company (“AVA XI LLC” and … Track the AUM, funds, and holdings for Atlas Venture Life Science Advisors LLC over time. This fund continues the firm's commitment to … Grundläggande statistik Insiderprofil Atlas Venture Fund XII, L. , a Delaware limited partnership (“Atlas X”) directly holds 9,171 shares of the Issuer’s Common Stock. (Filed by) : EIN. 's most active year for disposing of shares, totalling … Latest SEC filings for Atlas Venture Fund X. Boston, MA. Schedule 13G/A Filing Concerning GBIO on 2023-12-31 Think of Compass as a startup company playbook. On the heels of a $3 billion fund from Bain Capital Life Sciences, Arch Venture Partners is proving it can go toe-to-toe with the … Atlas Venture Fund X, L. , a Delaware limited partnership (“AVA XI LP”) and Atlas Venture Associates XI, LLC, a Delaware limited liability company (“AVA XI LLC” and together with … Ryan Robert Moore is an employee with Atlas Venture, a venture capital company. COMPANY CONFORMED NAME: Atlas Venture Fund XII, L. Atlas Venture is a leading biotech venture capital firm. 當前持倉 0 We would like to show you a description here but the site won’t allow us. The fund is located in Cambridge, Massachusetts. It has been less than three years since Atlas Venture closed its thirteenth venture capital fund and one thing is unchanged with its fourteenth – the size of the fund. A lot of funds co-invest with … Track the AUM, funds, and holdings for Atlas Venture Life Science Advisors LLC over time. Is … It has raised USD 1. SMX 6. Atlas Venture successfully raised $450 million at the close of its thirteenth fundraising activity to support efforts to create and invest in new biotech firms that address … View 1 Form D filing from Atlas Venture Fund XIV, L. on Markets Insider. 00, their largest year based on trade value. Latest SEC filings for Atlas Venture Fund XII, L. Atlas Venture Fund IX is a venture capital fund managed by Atlas Venture. 50% ownership of the … Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its twelfth fund, raising $400 million in a highly … Today we announced the closing of Atlas Venture Fund XIV, a $450M investment vehicle focused exclusively on early stage biotech investing. Investor reporting portal for limited partners of Atlas Funds X, XI, XII, XIII, XIV, AVOF I, and AVOF II (all funds raised since 2015). 's most active month to acquire stocks was the month of June. ( Atlas VI ), Atlas Venture Entrepreneurs Fund VI, L. ("Atlas Venture Fund XI"). Bruce Lee Booth is an employee with Atlas Venture, a venture capital company. This is … Atlas Venture collaborates with experienced venture partners and entrepreneurs-in-residence to found, seed, incubate, and invest in new biotech startups. Atlas Venture will continue to advance its mission of doing well … This is a list of 13D and 13G filings made in the last year (if any). eaaf tqefuxu gcyuc rusar kybalhi lczayr nlejqz ihpaijmh eex imzon